Premier, INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

BTS
Healthcare improvement company Premier, Inc. has completed its acquisition by Patient Square Capital for $2.6 billion, with stockholders receiving $28.25 per share in cash.
BTS
Premier, Inc. stockholders overwhelmingly approved the acquisition by an affiliate of Patient Square Capital for $28.25 per share, with the transaction expected to close around November 25, 2025.
BTS
Premier Inc. provides additional disclosures for its $28.25 per share acquisition by Patient Square Capital, addressing shareholder litigation.
BTS
Premier, Inc. reported a 3% decrease in total net revenue and a significant drop in GAAP net income for Q1 FY2026, while withdrawing future guidance due to its pending acquisition by Patient Square Capital.
BTS
Premier Inc. released its 2025 Sustainability Report, highlighting achievements in community health, ethics, supply chain, and environmental stewardship.
BTS
Premier, Inc. has entered into a definitive agreement to be acquired by an affiliate of Patient Square Capital for $28.25 per share in cash, valuing the transaction at approximately $2.6 billion.
BTS
Premier, Inc. reported better-than-expected fiscal year 2025 financial results, driven by strong Supply Chain Services, but anticipates a decline in fiscal year 2026 before returning to growth in fiscal year 2027.
BTS
Premier, Inc. is engaging investors and analysts with a presentation highlighting its corporate governance, growth strategy, and capital allocation ahead of its fiscal 2025 financial results announcement.
BTS
Premier Inc. announced positive Q3 2025 financial results, driven by better-than-expected performance in Supply Chain Services, leading to increased adjusted EBITDA and EPS guidance while reaffirming revenue guidance.
BTS
Premier, Inc. has entered into accelerated share repurchase agreements with JPMorgan Chase Bank to repurchase $200 million of its Class A common stock.
BTS
Premier Inc. reports mixed Q2 fiscal year 2025 results with revenue decline but reaffirms guidance midpoints and increases adjusted EPS guidance.
BTS
Premier, Inc. presented at the J.P. Morgan Healthcare Conference on January 14, 2025, and announced the completion of $600 million in share repurchases under its existing authorization.
BTS
Premier, Inc. successfully held its 2024 Annual Meeting, electing two Class II Directors, ratifying Ernst & Young as its auditor, and approving executive compensation on an advisory basis.
BTS
Premier, Inc. has appointed David Zito as President of Performance Services and announced the resignation of Chief Operating Officer Leigh Anderson, effective December 31, 2024.
BTS
Premier, Inc. announced its fiscal year 2025 first-quarter results, slightly exceeding expectations for revenue and profitability and reaffirming its full-year guidance.
BTS
Premier Inc. has released its 2024 Sustainability Report, showcasing its ongoing commitment to environmental stewardship, social responsibility, and governance excellence.
BTS
Premier, Inc. reported better-than-expected financial results for the fourth quarter and full fiscal year 2024, while also announcing a CEO transition and strategic divestitures.
BTS
Premier, Inc. has appointed Glenn Coleman as its new Chief Administrative and Financial Officer, succeeding Craig McKasson who will retire at the end of 2024.
BTS
Premier Inc.'s Board of Directors has approved changes to its executive equity award program, adding net revenue as a performance metric alongside adjusted earnings per share.
BTS
Premier Inc. is engaging with investors and stakeholders, providing an overview of their business model, growth strategy, and commitment to corporate governance.
BTS
Premier, Inc. reported a net loss for the third quarter due to a significant impairment charge, while reaffirming its full-year financial guidance and continuing its share repurchase program.
BTS
Premier Inc. has agreed to a $71 million settlement with its directors and officers insurance carriers to resolve a shareholder derivative lawsuit.
BTS
Premier Inc. has completed its strategic review, approved a $1 billion share repurchase program, and will seek partners for its Contigo Health and S2S Global businesses.
BTS
Premier Inc. has updated its bylaws to clarify the roles of the Vice Chair and Board Chair, incorporate a board age limit policy, and designate federal district courts as the exclusive forum for Securities Act claims.